GO
Loading...

Faber: Biogen's Tysabri Problematic

Wednesday, 12 Dec 2007 | 4:35 PM ET

Biogen's reintroduction of Tysabri was problematic, but the company backs guidance for 2007, reports CNBC's David Faber.